Cite
HARVARD Citation
Ottaiano, A. et al. (2022). Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials. Lancet oncology. 23 (4), pp. 452-454. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ottaiano, A. et al. (2022). Initial tumour burden and hidden oligometastatic disease in phase 3 clinical trials. Lancet oncology. 23 (4), pp. 452-454. [Online].